Grant Details
Grant Number: |
5R01CA073475-02 Interpret this number |
Primary Investigator: |
Martinez-Maza, Otoniel |
Organization: |
Children'S Hospital-La |
Project Title: |
Molecular Epidemiology of AIDS-Associated Lymphoma |
Fiscal Year: |
1998 |
Abstract
DESCRIPTION (adapted from the Abstract): Non-Hodgkin's B-cell lymphoma is
seen in greatly-elevated frequency in the acquired immunodeficiency syndrome
(AIDS) and in infection with the human immunodeficiency virus (HIV). In
this application, the Principal Investigator proposes studies to elucidate
the molecular epidemiology of AIDS-lymphoma. In preliminary work, the
Principal Investigator found that elevated serum levels of sCD23, as well as
elevated levels of other immune system molecules (IgE, sCD27), precede the
appearance of AIDS-lymphoma. Also, the elevated levels of sCD23 seen to
precede AIDS-lymphoma may be due to the production of this molecule by tumor
cells. In the proposed studies, the Investigator and associates will test
the hypotheses that the over-expression of sCD23 (and other molecules) that
precedes AIDS-lymphoma reflects: (1) immune dysfunction leading to B-cell
hyper-activation and enhanced Ig isotype switching, perhaps contributing to
the c-myc:Ig gene chromosomal translocation commonly seen in this cancer, or
alternatively, (2) the production of these substances (sCD23 and other
molecules) by the lymphoma cells themselves, or (3) reactivation of EBV
infection. Also, they will examine the predictive value of the expression
of these molecules for AIDS-lymphoma, and the expression of these molecules
in lymphoma not associated with HIV infection, including African endemic
Burkitt's lymphoma. Their specific aims are to: (1) define the pattern of
expression of sCD23 prior to the emergence of AIDS-lymphoma; (2)
determine/confirm which immune system molecules, other than sCD23, are
elevated in those who develop AIDS-lymphoma; (3) determine if the
measurement of serum levels of molecules other than sCD23 provides
additional information for predicting the appearance of AIDS-lymphoma; and
(4) determine if sCD23 or other immune system molecules are elevated in
non-Hodgkin's B-cell lymphoma not associated with HIV infection, or in
AIDS-lymphoma in hemophiliacs. The accomplishment of these specific aims
will add valuable new information to our understanding of the molecular
epidemiology of AIDS-lymphoma, as well as the role of immune dysfunction in
the generation and growth of this cancer.
Publications
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Authors: Breen E.C.
, Hussain S.K.
, Magpantay L.
, Jacobson L.P.
, Detels R.
, Rabkin C.S.
, Kaslow R.A.
, Variakojis D.
, Bream J.H.
, Rinaldo C.R.
, et al.
.
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2011 Jul; 20(7), p. 1303-14.
PMID: 21527584
Related Citations
Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.
Authors: Regidor D.L.
, Detels R.
, Breen E.C.
, Widney D.P.
, Jacobson L.P.
, Palella F.
, Rinaldo C.R.
, Bream J.H.
, Martínez-Maza O.
.
Source: Aids (london, England), 2011-01-28 00:00:00.0; 25(3), p. 303-14.
PMID: 21192231
Related Citations
HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.
Authors: Epeldegui M.
, Vendrame E.
, Martínez-Maza O.
.
Source: Immunologic Research, 2010 Dec; 48(1-3), p. 72-83.
PMID: 20717742
Related Citations
Cytokine signaling pathway polymorphisms and AIDS-related non-Hodgkin lymphoma risk in the multicenter AIDS cohort study.
Authors: Wong H.L.
, Breen E.C.
, Pfeiffer R.M.
, Aissani B.
, Martinson J.J.
, Margolick J.B.
, Kaslow R.A.
, Jacobson L.P.
, Ambinder R.F.
, Chanock S.
, et al.
.
Source: Aids (london, England), 2010-04-24 00:00:00.0; 24(7), p. 1025-33.
PMID: 20299965
Related Citations
Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma.
Authors: Widney D.P.
, Gui D.
, Popoviciu L.M.
, Said J.W.
, Breen E.C.
, Huang X.
, Kitchen C.M.
, Alcantar J.M.
, Smith J.B.
, Detels R.
, et al.
.
Source: Aids Research And Treatment, 2010; 2010, p. 164586.
PMID: 21490903
Related Citations
The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma.
Authors: Aissani B.
, Ogwaro K.M.
, Shrestha S.
, Tang J.
, Breen E.C.
, Wong H.L.
, Jacobson L.P.
, Rabkin C.S.
, Ambinder R.F.
, Martinez-Maza O.
, et al.
.
Source: Journal Of Acquired Immune Deficiency Syndromes (1999), 2009-10-01 00:00:00.0; 52(2), p. 170-9.
PMID: 19654554
Related Citations
Elevated expression of activation induced cytidine deaminase in peripheral blood mononuclear cells precedes AIDS-NHL diagnosis.
Authors: Epeldegui M.
, Breen E.C.
, Hung Y.P.
, Boscardin W.J.
, Detels R.
, Martínez-Maza O.
.
Source: Aids (london, England), 2007-11-12 00:00:00.0; 21(17), p. 2265-70.
PMID: 18090274
Related Citations
The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.
Authors: Cozen W.
, Cerhan J.R.
, Martinez-Maza O.
, Ward M.H.
, Linet M.
, Colt J.S.
, Davis S.
, Severson R.K.
, Hartge P.
, Bernstein L.
.
Source: Cancer Causes & Control : Ccc, 2007 Oct; 18(8), p. 821-31.
PMID: 17588155
Related Citations
Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
Authors: Epeldegui M.
, Hung Y.P.
, McQuay A.
, Ambinder R.F.
, Martínez-Maza O.
.
Source: Molecular Immunology, 2007 Feb; 44(5), p. 934-42.
PMID: 16730063
Related Citations
Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B cell activation-associated molecular lesions.
Authors: Epeldegui M.
, Widney D.P.
, Martínez-Maza O.
.
Source: Current Opinion In Oncology, 2006 Sep; 18(5), p. 444-8.
PMID: 16894291
Related Citations
Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
Authors: Breen E.C.
, Fatahi S.
, Epeldegui M.
, Boscardin W.J.
, Detels R.
, Martínez-Maza O.
.
Source: Tumour Biology : The Journal Of The International Society For Oncodevelopmental Biology And Medicine, 2006; 27(4), p. 187-94.
PMID: 16651853
Related Citations
Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection.
Authors: Widney D.P.
, Breen E.C.
, Boscardin W.J.
, Kitchen S.G.
, Alcantar J.M.
, Smith J.B.
, Zack J.A.
, Detels R.
, Martínez-Maza O.
.
Source: Journal Of Interferon & Cytokine Research : The Official Journal Of The International Society For Interferon And Cytokine Research, 2005 Nov; 25(11), p. 702-6.
PMID: 16318584
Related Citations
Elevated levels of soluble CD44 precede the development of AIDS-associated non-Hodgkin's B-cell lymphoma.
Authors: Breen E.C.
, Epeldegui M.
, Boscardin W.J.
, Widney D.P.
, Detels R.
, Martínez-Maza O.
.
Source: Aids (london, England), 2005-10-14 00:00:00.0; 19(15), p. 1711-2.
PMID: 16184051
Related Citations
Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated non-Hodgkin's lymphoma cell lines.
Authors: Widney D.
, Boscardin W.J.
, Kasravi A.
, Martínez-Maza O.
.
Source: Tumour Biology : The Journal Of The International Society For Oncodevelopmental Biology And Medicine, 2003 Mar-Apr; 24(2), p. 82-93.
PMID: 12853703
Related Citations
B-cell activation and lymphoma in patients with HIV.
Authors: Martínez-Maza O.
, Breen E.C.
.
Source: Current Opinion In Oncology, 2002 Sep; 14(5), p. 528-32.
PMID: 12192272
Related Citations
Viral interleukin 6 stimulates human peripheral blood B cells that are unresponsive to human interleukin 6.
Authors: Breen E.C.
, Gage J.R.
, Guo B.
, Magpantay L.
, Narazaki M.
, Kishimoto T.
, Miles S.
, Martínez-Maza O.
.
Source: Cellular Immunology, 2001-09-15 00:00:00.0; 212(2), p. 118-25.
PMID: 11748928
Related Citations
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
Authors: Widney D.
, Gundapp G.
, Said J.W.
, van der Meijden M.
, Bonavida B.
, Demidem A.
, Trevisan C.
, Taylor J.
, Detels R.
, Martínez-Maza O.
.
Source: Clinical Immunology (orlando, Fla.), 1999 Nov; 93(2), p. 114-23.
PMID: 10527687
Related Citations
Human herpesvirus 8-encoded interleukin 6 activates HIV-1 in the U1 monocytic cell line.
Authors: Gage J.R.
, Breen E.C.
, Echeverri A.
, Magpantay L.
, Kishimoto T.
, Miles S.
, Martínez-Maza O.
.
Source: Aids (london, England), 1999-10-01 00:00:00.0; 13(14), p. 1851-5.
PMID: 10513642
Related Citations
The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.
Authors: Breen E.C.
, van der Meijden M.
, Cumberland W.
, Kishimoto T.
, Detels R.
, Martínez-Maza O.
.
Source: Clinical Immunology (orlando, Fla.), 1999 Sep; 92(3), p. 293-9.
PMID: 10479534
Related Citations
Immune dysfunction and the pathogenesis of AIDS-associated non-Hodgkin's lymphoma.
Authors: Martínez-Maza O.
, Widney D.
, van der Meijden M.
, Knox R.
, Echeverri A.
, Breen E.C.
, Magpantay L.
, Miles S.A.
.
Source: Memo¿rias Do Instituto Oswaldo Cruz, 1998 May-Jun; 93(3), p. 373-81.
PMID: 9698872
Related Citations